Biostar Pharmaceuticals (BSPM) Swings to Q3 Loss of 63c/Share

Biostar Pharmaceuticals (NASDAQ: BSPM) reported Q3 EPS of ($0.63), versus $0.47 reported last year. Revenue for the quarter came in at $9.97 million, versus $24.78 million reported last year.

For earnings history and earnings-related data on Biostar Pharmaceuticals (BSPM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Nkarta Inc. (NKTX) PT Lowered to $10 at Stifel as Ntrust-1/2 Trial Enrollment Progresses